Literature DB >> 30602481

The Vaginal Microbiome of Transgender Men.

Gabrielle Winston McPherson1, Thomas Long1, Stephen J Salipante1, Jessica A Rongitsch2, Noah G Hoffman1, Karen Stephens1, Kelsi Penewit1, Dina N Greene3.   

Abstract

BACKGROUND: Hormonal changes influence the composition of vaginal flora, which is directly related to the health of an individual. Transgender men prescribed testosterone experience a vaginal hormone composition that differs from cisgender women. To the author's knowledge, there are no clinical studies evaluating the influence that testosterone administration has on the vaginal microbiome.
METHODS: Vaginal swabs were self-collected by a cohort of self-identified healthy transgender men prescribed testosterone for at least 1 year (n = 28) and from cisgender women who were used as the comparator (n = 8). Participants completed a questionnaire to indicate the mode and dose of testosterone administration, sexual history, and vaginal health. Serum was collected for hormone analysis. Bacterial community profiles were assessed with broad-range PCR primers targeting the V3-V4 hypervariable region of the 16S bacterial rRNA, next-generation sequencing, and analysis by phylogenetic placement.
RESULTS: Compared to cisgender women, the vaginal floras of transgender men were less likely to have Lactobacillus as their primary genus. Intravaginal estrogen administration was positively associated with the presence of Lactobacillus in transgender men (P = 0.045). Transgender men had a significantly increased relative abundance of >30 species and a significantly higher α diversity (P = 0.0003). The presence of Lactobacillus was significantly associated with a lower α diversity index (P = 0.017).
CONCLUSIONS: The vaginal microbiome of transgender men who were assigned a female sex at birth and use testosterone may differ from that of cisgender women. Intravaginal estrogen administration may reduce these differences by promoting colonization with Lactobacillus species and decreasing α diversity.
© 2018 American Association for Clinical Chemistry.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30602481     DOI: 10.1373/clinchem.2018.293654

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

1.  Cervicovaginal cytology, HPV testing and vaginal flora in transmasculine persons receiving testosterone.

Authors:  Lawrence Hsu Lin; Fang Zhou; Esther Elishaev; Samer Khader; Andrea Hernandez; Alan Marcus; Esther Adler
Journal:  Diagn Cytopathol       Date:  2022-08-08       Impact factor: 1.390

Review 2.  HIV Pathogenesis in the Human Female Reproductive Tract.

Authors:  Marta Rodriguez-Garcia; Kaleigh Connors; Mimi Ghosh
Journal:  Curr HIV/AIDS Rep       Date:  2021-03-15       Impact factor: 5.495

3.  The healthy female microbiome across body sites: effect of hormonal contraceptives and the menstrual cycle.

Authors:  Maria Christine Krog; Luisa W Hugerth; Emma Fransson; Zahra Bashir; Anders Nyboe Andersen; Gabriella Edfeldt; Lars Engstrand; Ina Schuppe-Koistinen; Henriette Svarre Nielsen
Journal:  Hum Reprod       Date:  2022-06-30       Impact factor: 6.353

4.  Daily Vaginal Microbiota Fluctuations Associated with Natural Hormonal Cycle, Contraceptives, Diet, and Exercise.

Authors:  Stephanie D Song; Kalpana D Acharya; Jade E Zhu; Christen M Deveney; Marina R S Walther-Antonio; Marc J Tetel; Nicholas Chia
Journal:  mSphere       Date:  2020-07-08       Impact factor: 4.389

Review 5.  The Effect of Gender-Affirming Medical Care on the Vaginal and Neovaginal Microbiomes of Transgender and Gender-Diverse People.

Authors:  Yonah Krakowsky; Emery Potter; Jason Hallarn; Bern Monari; Hannah Wilcox; Greta Bauer; Jacques Ravel; Jessica L Prodger
Journal:  Front Cell Infect Microbiol       Date:  2022-01-21       Impact factor: 5.293

Review 6.  Gut and vaginal microbiomes on steroids: implications for women's health.

Authors:  Madeline E Graham; William G Herbert; Stephanie D Song; Harshini N Raman; Jade E Zhu; Paulina E Gonzalez; Marina R S Walther-António; Marc J Tetel
Journal:  Trends Endocrinol Metab       Date:  2021-05-25       Impact factor: 10.586

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.